Efficacy and safety of semaglutide in glycemic control, body weight management, lipid profiles and other biomarkers among obese type 2 diabetes patients initiated or switched to semaglutide from other GLP-1 receptor agonists

PURPOSE: Evidence of the efficacy and safety of semaglutide among patients with type 2 diabetes who were initiated on or were switched to semaglutide from other GLP-1 RAs remains limited. The objective of this study was to investigate the short-term effects of switching to semaglutide from other GLP...

Descripción completa

Detalles Bibliográficos
Autores principales: Okamoto, Aki, Yokokawa, Hirohide, Nagamine, Tomoko, Fukuda, Hiroshi, Hisaoka, Teruhiko, Naito, Toshio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8630305/
https://www.ncbi.nlm.nih.gov/pubmed/34900848
http://dx.doi.org/10.1007/s40200-021-00899-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8630305/
https://www.ncbi.nlm.nih.gov/pubmed/34900848
http://dx.doi.org/10.1007/s40200-021-00899-9

Ejemplares similares